Radiation Planning Study for High Grade Brain Tumors
3T Versus 1.5T MR Approaches in Target Definition for Malignant Gliomas: Is There a Significant Difference in Tumor Extent and Radiation Treatment Volume?
1 other identifier
observational
24
1 country
1
Brief Summary
The purpose of this research study is to see if a higher strength MRI procedure provides better images to use in planning radiation treatments for patients with brain tumors in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 25, 2010
CompletedFirst Posted
Study publicly available on registry
August 30, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedAugust 22, 2017
December 1, 2014
2.8 years
August 25, 2010
August 21, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Treatment volume
To assess the difference in treatment volume for radiation planning in gliomas as calculated using 1.5T versus 3T magnets
1 year average
Study Arms (1)
3T MRI
Patients receiving 3T MRI
Interventions
Eligibility Criteria
Patients with high grade glioma planning to receive radiation therapy
You may qualify if:
- Histologically confirmed, newly diagnosed Grade III-IV glioma
- Planning to undergo radiation therapy
You may not qualify if:
- Grade I or II glioma
- Patients unable to undergo MRI imaging
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Cincinnati
Cincinnati, Ohio, 45219, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Guarnaschelli, MD
University of Cincinnati
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Clinical Trials
Study Record Dates
First Submitted
August 25, 2010
First Posted
August 30, 2010
Study Start
June 1, 2010
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
August 22, 2017
Record last verified: 2014-12
Data Sharing
- IPD Sharing
- Will not share